January 28th
Roqiya Bouguerra (Toso lab)
Immunotherapy in the surgical management of hepatocellular carcinoma
Louis Kunz (Vozenin lab)
FLASH sparing effect is transcriptionally regulated
March 18th
Qun Zeng (Scheiermann lab)
Circadian anti-tumor immune responses
Alexey Koval (Katanaev lab)
Defining pharmacological utility of Wnt receptor Frizzled 5 in cancers through novel, selective small-molecule inhibitors
April 22nd
Emeline Boët (Tamburini lab)
Phagocytic inflammatory AML cells as drivers of therapy resistance and targets for precision treatment
Laure Garnier (Hugues lab)
CCL19+ Cancer-Associated Fibroblasts (CAFs) orchestrate response to anti-PD-1 therapy in breast cancer
June 10th - Distinguished lecturer
Ido Amit (HHMI International Research Scholar, Director Weizmann Immunotheraphy Center, Eden and Steven Romick Professorial Chair, Laboratory for Immuno-Genomics | Weizmann Institute of Science)
Leveraging Single-Cell Technologies to Engineer the Immune System
June 24th
Jonatan Bonjour (Michielin-Cuendet lab)
Spatial biomarkers for immunotherapy response prediction
Pablo Jané (HUG)
The Imageable & Theranostic Genomes
September 16th
Benedetta Fiordi (Jandus lab)
AML blasts shed TREM2 to inhibit group 1 ILC function
Doha Boukaoui (Cohen lab)
Development of methotrexate-loaded nanoparticles targeting PD-L1 for the treatment of gestational trophoblastic neoplasia
October 28th
Mathilde Bausart (Hugues lab)
Lymphatic endothelial cell immunomodulatory functions are shaped by the tumor microenvironment
Josep Garnica (Carmona lab)
All scRNAseq cell type annotations are wrong, some are useful. How useful are yours?
November 18th
Joanna Sobocinska (Cuendet lab)
Targeting HDAC6 sensitizes lung adenocarcinoma cells to vinorelbine
Roqiya Bouguerra (Toso lab)
Hepatectomy alters adjuvant anti-PD-1 action in a mouse model of HCC but does not compromise neoadjuvant efficacy
December 16th
Cristian Angeli (Tsantoulis lab)
Tumoroid-based drug screening
Jakub Gubala (Nowak-Sliwinska lab)
Towards Understanding of CAF–Tumor crosstalk in Renal Cell Carcinoma and its implications for precision oncology
